drugset / Trial / NCT00817765
Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the influence of posaconazole on unboosted fosamprenavir pharmacokinetics, and vice versa, in healthy volunteers.A second objective is to determine the safety of combined use of fosamprenavir with posaconazole in healthy volunteers.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-07
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fosamprenavir | Small molecule | 700 mg | Oral |
| Subject | Posaconazole | Small molecule | 400 mg | Oral |
| Comparator | Ritonavir | Other / unclassified | 100 mg | Oral |